OPRM1 and CYP3A4 association with methadone dose in Iranian patients undergoing methadone maintenance therapy.

CYP3A4 and OPRM1 single variations cannot explain variability in methadone dosage in MMT. Studying the interactions of more genetic factors in larger samples may elucidate factors influencing the required dose of methadone and better individualized therapy.